Investing

MannKind : MNKD

MNKD

Stock Data

$2.84

$0.01 (0.35%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

MannKind Corporation is a pioneering biopharmaceutical firm dedicated to creating inhaled therapeutic products for diabetes and rare lung diseases. Its flagship product, Afrezza, is an innovative inhaled insulin offering a new approach to glycemic control in adults. Additionally, MannKind is developing treatments for pulmonary arterial hypertension and other serious lung conditions. With strategic partnerships for global distribution and a commitment to advancing respiratory health, MannKind stands at the forefront of inhalation technology for medical treatments.

All MannKind Articles

305 Articles

Chris Lange | Jun 28, 2021 at 8:05 AM EDT

Cramer’s Stock Picks at the Market Top

24/7 Wall St. takes a look at famed market personality Jim Cramer’s latest buy and sell recommendations and overall analysis.

Chris Lange | Aug 12, 2020 at 8:25 AM EDT

Short Sellers Shy Away From Big Biotech

The July 31 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Jul 27, 2020 at 9:41 AM EDT

Big Biotechs Scare Off Short Sellers

The July 15 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Jul 13, 2020 at 9:43 AM EDT

Short Sellers Can’t Make Up Their Minds on Big Biotechs

The June 30 short interest data has been compared with the previous report, and short interest moves in these selected…

Chris Lange | Jun 25, 2020 at 9:46 AM EDT

Short Sellers Run for Cover From Major Biotechs

The June 15 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Jun 10, 2020 at 10:01 AM EDT

Major Biotechs Have Short Sellers on the Run

The May 29 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | May 28, 2020 at 9:37 AM EDT

Major Biotechs See More Targeted Short Sellers

The May 15 short interest data has been compared with the previous report, and short interest moves in these selected…

Chris Lange | May 12, 2020 at 9:36 AM EDT

Short Sellers Raise the Stakes in Major Biotechs

The April 30 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Apr 27, 2020 at 8:47 AM EDT

Short Sellers Grow More Selective on Major Biotechs

The April 15 short interest data has been compared with the previous report, and short interest moves in these selected…

Chris Lange | Apr 13, 2020 at 9:40 AM EDT

Big Biotechs Scare Off Short Sellers

The March 31 short interest data has been compared with the previous report, and short interest in these selected biotech…

Chris Lange | Mar 25, 2020 at 9:45 AM EDT

Major Biotechs Get Mixed Message on Short Interest

The March 13 short interest data has been compared with the previous report, and short interest moves in these selected…

Chris Lange | Mar 11, 2020 at 9:13 AM EDT

Big Biotechs Have Short Sellers Confused

The February 28 short interest data has been compared with the previous report, and short interest moves in these selected…

Chris Lange | Feb 27, 2020 at 8:35 AM EST

Major Biotechs Have Short Sellers Confused

The February 14 short interest data has been compared with the previous report, and short interest moves in these selected…

Chris Lange | Feb 12, 2020 at 8:45 AM EST

Biotech Short Sellers Focus on a Couple Favorites

The January 31 data has been compared with the previous report, and short interest in most of these selected biotech…

Chris Lange | Jan 28, 2020 at 8:45 AM EST

Short Sellers Wary on Major Biotechs

The January 15 short interest data has been compared with the previous report, and short interest in most of these…